Latest News & Updates

Breaking News

  • 2 minutes ago

  • Simantini Singh Deo

MacroGenics, Inc. Announces FDA Lifts Partial Clinical Hold On Phase 2 LINNET Study, Allowing Enrollment To Resume Under Updated Safety Protocol
Breaking News
Psyence Biomedical Ltd. Expands Australian Clinical Site Network From Three To Five Locations To Support Ongoing Phase IIb Natural Psilocybin Trial

Simantini Singh Deo

Other trending news you may like to read

Psyence Biomedical Ltd. Expands Australian Clinical Site Network From Three To Five Locations To Support Ongoing Phase IIb Natural Psilocybin Trial

Psyence Biomedical expands Australian sites from 3 to 5 for Phase IIb NPX-5 psilocybin trial in Adjustment Disorder in cancer patients, improving recruitment and study execution.

Simantini Singh Deo

Pharma Now

Remedy Plan Therapeutics Appoints Jotin Marango, M.D., Ph.D., As New CFO & CBO To Lead Financial And Strategic Growth

Remedy Plan Therapeutics appoints Jotin Marango as CFO & CBO to drive financial strategy and support oncology pipeline growth, including advancement of its NAMPT inhibitor program.

Simantini Singh Deo

Pharma Now

RenovoRx Receives First Japanese Notice Of Allowance For Patent Protecting Its RenovoCath® Device For Targeted Drug Delivery Through The Vasa Vasorum

RenovoRx receives Japan Notice of Allowance for RenovoCath device enabling targeted drug delivery via vasa vasorum, strengthening its oncology platform and global IP portfolio.

Simantini Singh Deo

Pharma Now

Spectral AI, Inc. Appoints David McGuire As Chief Financial Officer, Effective May 4, 2026, To Strengthen Financial Leadership Ahead Of DeepView® Commercialization

Spectral AI appoints David McGuire as CFO ahead of DeepView System commercialization in wound care, strengthening financial leadership to support growth and market expansion.

Simantini Singh Deo

Pharma Now